PRECISION BIOSCIENCES INC
Datakwaliteit: 100%
DTIL
NASDAQ
Manufacturing
Chemicals
€ 7,23
▲
€ 0,10
(1,40%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-26,20%
Groei
Revenue Growth (5Y)
-26,20%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-50,12%
Earnings (1Y)-737,98%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-180,41%
Onder sectorgemiddelde (-54,49%)
ROIC-47,39%
Net Margin-133,45%
Op. Margin-152,19%
Veiligheid
Debt / Equity
N/A
Current Ratio3,45
Interest Coverage-36,67
Waardering
PE (TTM|NTM)
-3,65 | -1,96
Onder sectorgemiddelde (-1,50)
P/B Ratio10,04
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -26,20% annually over 5 years
Earnings declined -737,98% over the past year
Negative free cash flow of -65,84 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23,92%
Price History
Financiële Trends
Koersdoel Analisten
4 analisten
Buy
+342.6%
upside to target
Huidig
€ 7,23
Consensus Target
€ 32,00
€ 19,00
Laag
€ 60,00
Hoog
Vooruitzicht
Forward K/W
-1,96
Forward WPA
-€ 3,40
Omzet Sch.
12,90 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,80
·
Rev Est: 4,05 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -€ 2,21 | -€ 2,13 | -€ 1,84 | € 1,01 | — | — |
| Estimate | -€ 2,42 | -€ 2,21 | -€ 2,21 | -€ 0,64 | -€ 0,80 | -€ 0,92 |
| Verrassing | +8,68% | +3,40% | +16,74% | +256,36% | — | — |
Growth
Rev 5Y: -26,20% · Earnings 1Y: -737,98%
Growth
Rev 5Y: -26,20% · Earnings 1Y: -737,98%| Revenue Growth (1Y) | -50,12% | Revenue Growth (3Y) | -16,14% |
| Earnings Growth (1Y) | -737,98% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -26,20% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -180,41% · Net Margin: -133,45%
Profitability
ROE: -180,41% · Net Margin: -133,45%| Revenue (TTM) | 34,26 M | Net Income (TTM) | -45,72 M |
| ROE | -180,41% | ROA | -45,17% |
| Gross Margin | N/A | Operating Margin | -152,19% |
| Net Margin | -133,45% | Free Cash Flow (TTM) | -65,84 M |
| ROIC | -47,39% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 3,45
Safety
D/E: N/A · Current: 3,45| Debt / Equity | N/A | Current Ratio | 3,45 |
| Interest Coverage | -36,67 | Asset Turnover | 0,34 |
| Working Capital | 36,71 M | Tangible Book Value | 15,65 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -3,65 · EV/EBITDA: N/A
Valuation
P/E: -3,65 · EV/EBITDA: N/A| P/E Ratio | -3,65 | Forward P/E | -1,96 |
| P/B Ratio | 10,04 | P/S Ratio | 4,87 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 12,94 | Fwd Earnings Yield | N/A |
| FCF Yield | -39,44% | ||
| Market Cap | 166,95 M | Enterprise Value | 122,08 M |
Per Share
EPS: -3,56 · FCF/Share: -2,55
Per Share
EPS: -3,56 · FCF/Share: -2,55| EPS (Diluted TTM) | -3,56 | Revenue / Share | 1,33 |
| FCF / Share | -2,55 | OCF / Share | -2,55 |
| EPS CAGR (1Y) | -442,31% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 144,00% · CapEx/Rev: N/A
Efficiency
FCF Conv: 144,00% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 144,00% |
| SBC-Adj. FCF | -77,19 M | Growth Momentum | -23,92 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 34,26 M | 68,70 M | 48,73 M | 25,10 M | 115,53 M |
| Net Income | -45,72 M | 7,17 M | -61,32 M | -111,64 M | -30,60 M |
| EPS (Diluted) | -3,56 | 1,04 | -15,96 | -1,27 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -52,15 M | -26,16 M | -43,74 M | -100,37 M | -39,40 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 54,17 M | 59,56 M | 53,38 M | 83,94 M | 115,24 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 1,47 M | 3,40 M | 6,82 M | 7,80 M | 8,98 M |
| Interest Expense | 1,42 M | 1,78 M | 2,23 M | 1,11 M | 132.000,0 |
| Income Tax | 0,0 | — | — | — | 23.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 154,42 M | 136,39 M | 159,78 M | 238,17 M | 211,50 M |
| Total Liabilities | 62,17 M | 80,00 M | 140,92 M | 177,74 M | 120,33 M |
| Shareholders' Equity | 92,25 M | 56,39 M | 18,86 M | 60,43 M | 91,17 M |
| Total Debt | — | — | 22,22 M | 22,22 M | 2,48 M |
| Cash & Equivalents | 110,82 M | 85,90 M | 116,68 M | 189,58 M | 143,66 M |
| Current Assets | 118,74 M | 94,99 M | 136,36 M | 199,11 M | 161,75 M |
| Current Liabilities | 8,91 M | 14,98 M | 49,99 M | 59,66 M | 35,98 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,7 | -1,5 |
| P/B | 10,0 | 1,6 |
| ROE % | -180,4 | -54,5 |
| Net Margin % | -133,5 | -41,5 |
| Rev Growth 5Y % | -26,2 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"DTIL","listing_kind":"stock","pathname":"/stocks/dtil","exchange":"NASDAQ","country":"US"}}